Song YQ, Zhang HL, Huang HQ, Zhang QY, et al. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma. Haematologica 2023 Oct 19. doi: 10.3324/haematol.2023.283802.
PMID: 37855035